Quest Diagnostics Incorporated (DGX)

NYSE HEALTHCARE
$195.00 -1.40% RSI 36 Neutral Add Alert

Moving Averages

SMA 200
$189.20
Price above

Company Profile

Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Sector
HEALTHCARE
Industry
DIAGNOSTICS & RESEARCH
Market Cap
$22.48B
P/E Ratio
22.41
EPS
$9.06
Beta
0.587
Dividend Yield
1.60%
52-Week High
$212.58
52-Week Low
$162.47

Similar stocks in DIAGNOSTICS & RESEARCH

TMO
Thermo Fisher Scientific Inc
RSI 46.0
ILMN
Illumina Inc
RSI 57.0
MTD
Mettler-Toledo International Inc
RSI 48.0
CSTL
Castle Biosciences Inc
RSI 51.0
FONR
Fonar Corp
RSI 75.0
CRL
Charles River Laboratories International Inc
RSI 57.0
BDSX
Biodesix Inc
RSI 62.0
NTRA
Natera Inc
RSI 62.0
WGS
GeneDx Holdings Corp - Class A
RSI 57.0
NEO
Neogenomics Inc
RSI 35.0

Data last updated: June 14, 2026 at 12:48 PM EDT

Track DGX for free

Get e-mail RSI alerts when Quest Diagnostics Incorporated enters oversold or overbought territory. Free forever.

Add Alert